[Epstein-Barr virus (EBV) infection associated with nasopharyngeal carcinoma]. 1990

M Furukawa
Dept. of Otorhinolaryngology, School of Medicine, Kanazawa University.

Etiopathogenesis of nasopharyngeal carcinoma (NPC) is not fully understood yet. However, extensive research in this area has produced significant observations which facilitate the elucidation of the etiological factors and pathogenesis. A. Etiological Factors (a) EBV: EBV serological profiles in NPC patients, presence of EBV fingerprints in NPC tumor cells, and similar terminal repeat copies of EBV-DNA in NPC tissues strongly suggest the etiological role of EBV in NPC. (b) Genetic: Evidence supporting the genetic role in the etiology of NPC are mainly epidemiological. Although HLA studies have shown an increased relative risk in Chinese with A2, and BW 46 and in Malays with B17 and B18, the significance is not high. (c) Other environmental factors: In vitro studies have indicated the possibility of factors such as salted fish, dry fish, fermented vegetables, processed meat and some Chinese traditional herbal medicines. (d) Depressed cell-mediated immunity (CMI): While humoral antibodies to various EBV antigens are raised, the CMI seems to be lowered in NPC. It is not known, however, whether depressed CMI is the effect or the cause of NPC. B. Pathogenesis (a) Receptors for EBV: The receptors for EBV, C3d receptors, exist on cells of the basal layers which are undergoing metaplastic or hyperplastic change. These cells are close to the underlying stroma which contain the lymphocytes harbouring EBV. A pre-NPC stage of metaplasia/hyperplasia and sero epidemiological studies show raised EBV antibody titer 3-5 years before the development of NPC. (b) All NPC originate from the fossa of Rosenmüller which is a recessed depression behind the torus tubarius. This space can permit prolonged contact between environmental agents and the epithelial cells.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D015342 DNA Probes Species- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. Chromosomal Probes,DNA Hybridization Probe,DNA Probe,Gene Probes, DNA,Conserved Gene Probes,DNA Hybridization Probes,Whole Chromosomal Probes,Whole Genomic DNA Probes,Chromosomal Probes, Whole,DNA Gene Probes,Gene Probes, Conserved,Hybridization Probe, DNA,Hybridization Probes, DNA,Probe, DNA,Probe, DNA Hybridization,Probes, Chromosomal,Probes, Conserved Gene,Probes, DNA,Probes, DNA Gene,Probes, DNA Hybridization,Probes, Whole Chromosomal

Related Publications

M Furukawa
June 2000, JPMA. The Journal of the Pakistan Medical Association,
M Furukawa
October 2017, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
M Furukawa
August 1992, Infectious agents and disease,
M Furukawa
February 1987, Hawaii medical journal,
M Furukawa
January 1974, Annals of clinical and laboratory science,
M Furukawa
August 2015, Zhonghua er ke za zhi = Chinese journal of pediatrics,
M Furukawa
March 2006, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!